About Olema Oncology Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and ...
Dr. Mark Ashley, honored as National Luminary of the Year, joins fellow industry leaders at the Brain Injury Association of America (BIAA) Luminary Event: (L–R) Dr. Brent Masel, BIAA National Medical ...
AI and Medical Technology company Echo IQ (“the Company” or “Echo IQ”) (ASX: EIQ), today announced that Dustin Haines, Chief Executive Officer, will participate in a fireside chat at the upcoming ...
The 8 th Annual Evercore Healthcare Conference Format: Fireside Chat Host: Jonathan Miller Date and Time: Tuesday, December 2, 2025; 4:15 pm - 4:35 PM EST. Location: Sevilla A, Track 2, the Loews ...
Platform-triggered SMS engagement delivers a 98% open rate and achieves actionable patient responses within 90 seconds—nearly 60x faster than email or phone outreach—a finding confirmed in 2025 ...
The research study evaluating Bucillamine remains in progress, and the Company is awaiting the final findings, which will be released only with the express authorization of DRDC. Revive will continue ...
8th Annual Evercore Healthcare Conference Wednesday, December 3, 2025, at 8:20 A.M. Eastern Time (ET) Piper Sandler 37th Annual Healthcare Conference Wednesday, December 3, 2025, at 11:00 A.M. Eastern ...
About OKYO OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain and dry eye disease, with ...
This acceptance follows Sangamo’s meeting with the FDA in October 2025 to discuss the proposed efficacy and safety data package for isaralgagene civaparvovec where, in the meeting minutes, among other ...
The B-FREE Chronic Babesiosis Study ( NCT06656351) is a Phase 2 open-label study that will evaluate the efficacy (and safety) of the ARAKODA ® regimen of tafenoquine over 90 days for resolution of ...
The live conference call webcast will be accessible in the Investors section of the Company’s web site and directly via the following link: For those who cannot listen to the live broadcast, an online ...
Investors interested in arranging a meeting with company management during the conference should contact the Piper Sandler conference coordinator. A live audio webcast of the presentation can be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results